About Us
SPE Capital is a boutique private equity firm formed in 2016 from a spinout from Swicorp, a leading regional investment banking firm
Our values
World class professional excellence and commitment
to the highest ethical standards
Professional Excellence
SPE Capital strives to provide the highest levels of quality in everything it does in order to deliver exceptional service. We strive to attract, develop and retain the best people from many diverse backgrounds and cultures.
Commitment
SPE Capital focuses on building lasting relationships based on trust and mutual respect. We foster a culture in which the interests of clients and investors are placed ahead of those of the company and employees are encouraged to always go ‘the extra mile’ to help realize their goals.
Integrity
SPE Capital has an unyielding commitment to the highest standards of ethical behavior, corporate governance and compliance with all laws and regulations wherever the firm conducts business.
Entrepreneurship
SPE Capital has an engrained performance-driven culture which encourages leadership, creativity and accountability, with each individual expected to share an owner’s mentality and take personal responsibility for delivering value for clients and investors.
Teamwork & Collaboration
SPE Capital seeks to foster a strong culture of teamwork and collaboration with a ‘One Firm’ approach in order to leverage its expertise, resources and network of relationships and ensure that its full range of skills, insights and experience may be used for the benefit of clients and investors.
Our investments
We focus on a select number of sectors including manufacturing
production and processing, services to industry
and human capital
News & Media
Final close of SPE AIF I
SPE Capital Partners (“SPE Capital”) today announced the final close of SPE AIF I, an Africa-focused private equity fund. SPE AIF I was oversubscribed and closed…
Stéphane Heuzé
SPE Capital is pleased to announce that Stéphane Heuzé has joined the firm as a Managing Partner, to be based out of the Casablanca office.
Saham Pharma
SPE AIF I and Proparco acquire Saham Pharma, a leading antibiotics manufacturer and major hospital provider in Morocco